by The hospital surgical disinfectants market consists of various disinfectant products such as skin disinfectants, instrument disinfectants, and surface disinfectants used to reduce or eliminate microorganisms from inanimate objects in healthcare settings. These disinfectants are widely used for sterilization of critical and semi-critical instruments to prevent the spread of nosocomial infections.
The Global Hospital Surgical Disinfectants Market is estimated to be valued at US$ 4.05 Bn in 2024 and is expected to exhibit a CAGR of 17% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Hospital Surgical Disinfectants are BMW Group, Mastercard, Daimler Ag, Amazon, Ford Motor Company, Volkswagen Ag, Honda Motor Co., Ltd., General Motors Company, and Hyundai Motor. These players are focusing on developing advanced disinfectants with fast-acting formulations and ensuring their products meet regulatory standards for efficacy and safety.
The growing demand for hospital-acquired infection control and prevention products is a major factor fueling the growth of the Hospital Surgical Disinfectants Market Share. With increasing surgical procedures and risk of infections, there is high demand for reliable and effective disinfectants. Various awareness campaigns by healthcare agencies and governments are also driving the adoption of disinfectants.
The market is witnessing significant expansion in developing regions due to improving healthcare infrastructure and surging patient population. Major players are focusing on strengthening their distribution network in Latin America, Asia Pacific, and Middle East & Africa to tap the growth opportunities in emerging markets.
Market Key Trends
One of the key trends in the hospital surgical disinfectants market is the growing demand for sporicidal disinfectants. Emergence of spore-forming pathogens such as C. difficile has increased the need for sporicidal agents with high efficacy against bacterial spores. Players have launched disinfectants containing aldehydes, hydrogen peroxide, and combination chemistry to eliminate spores and protect patients and staff from infections.
Porter’s Analysis
Threat of new entrants: High capital requirements and economies of scale serve as entry barriers for new companies entering this market.
Bargaining power of buyers: Buyers have moderate bargaining power considering the availability of alternatives and requirement to adhere to strict healthcare safety standards.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of alternative supply sources and lack of differentiation in core ingredients and technologies.
Threat of new substitutes: Threat of new substitutes is low as currently no substitute offers the same level of sterilization and disinfection required to ensure the safety of surgical procedures.
Competitive rivalry: The market is highly fragmented with presence of several global and regional players competing based on product portfolio and pricing.
Geographically, North America accounts for the largest share of the global hospital surgical disinfectants market mainly due to stringent regulations regarding infection control and prevention of hospital acquired infections in this region. The United States is the largest market for hospital surgical disinfectants in North America.
The Asia Pacific hospital surgical disinfectants market is expected to grow at the fastest rate during the forecast period. This is attributed to factors such as growing healthcare industry, increasing demand for advanced sterilization & disinfection products along with rising patient volume and number of surgeries performed in countries such as China and India. Growing medical tourism and government focus on improving healthcare infrastructure will further aid market growth.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it.
